Disparities in Reported Reasons for Not Initiating or Stopping Antiretroviral Treatment Among a Diverse Sample of Persons Living with HIV
Open Access
- 18 November 2008
- journal article
- research article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 24 (2), 247-251
- https://doi.org/10.1007/s11606-008-0854-z
Abstract
Disparities in the use of antiretroviral therapy (ART) for HIV disease have been documented across race, gender, and substance use groups. The current analysis compares self-reported reasons for never taking or stopping ART among a diverse sample of men and women living with HIV. Cross-sectional interview. HIV + (N = 3,818) adults, 968 of whom reported discontinuing or never using ART. Computerized self-administered and interviewer-administered self-reported demographic and treatment variables, including gender, race, ethnicity, CD4 count, detectable viral load, and reported reasons for not taking antiretroviral therapy. Despite equivalent use of ART in the current sample, African-American respondents were 1.7 times more likely to report wanting to hide their HIV status and 1.7 times more likely to report a change in doctors/clinics as reasons for stopping ART (p = .049, and p = .042) and had odds 4.5 times those of non-African Americans of reporting waiting for viral marker counts to worsen (p = < .0001). There was a lower tendency (OR = 0.4) for women to endorse concerns of keeping their HIV status hidden as a reason for stopping ART compared to men (p = .003). Although those with an IDU history were less likely to be on ART, no differences in reasons for stopping or never initiating ART were found between those with and without an IDU history. A desire to conceal HIV status as well as a change in doctors/clinics as reasons for discontinuing ART were considerably more common among African Americans, suggesting that perceived HIV/AIDS stigma is an obstacle to maintenance of treatment. Findings also indicate differences in reasons for stopping ART by gender and a perceived desire to wait for counts to worsen as a reason for not taking ART by African Americans, regardless of detectable viral load, CD4 count, age, education, employment, sexual orientation, and site.Keywords
This publication has 20 references indexed in Scilit:
- Association of Race and Gender with Use of Antiretroviral Therapy Among HIV-infected Individuals in the Southeastern United StatesSouthern Medical Journal, 2007
- Making the Connection: The Importance of Engagement and Retention in HIV Medical CareAIDS Patient Care and STDs, 2007
- Retention in Care: A Challenge to Survival with HIV InfectionClinical Infectious Diseases, 2007
- Differential Diffusion of HIV Technologies By Gender: The Case of Highly Active Antiretroviral TherapyAIDS Patient Care and STDs, 2007
- The Healthy Living Project: An Individually Tailored, Multidimensional Intervention for HIV–Infected PersonsAIDS Education and Prevention, 2005
- Theory-Guided, Empirically Supported Avenues for Intervention on HIV Medication Nonadherence: Findings from the Healthy Living ProjectAIDS Patient Care and STDs, 2003
- Responding to racial and ethnic disparities in use of HIV drugs: analysis of state policiesPublic Health Reports®, 2002
- Responding to Racial and Ethnic Disparities in Use of HIV Drugs: Analysis of State PoliciesPublic Health Reports®, 2002
- Prevalence and Predictors of Highly Active Antiretroviral Therapy Use in Patients With HIV Infection in the United StatesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Prevalence and Predictors of Highly Active Antiretroviral Therapy Use in Patients With HIV Infection in the United StatesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000